Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1956 2
1958 3
1959 3
1960 6
1962 8
1963 10
1964 5
1965 8
1966 4
1967 4
1968 4
1969 6
1970 1
1971 9
1972 5
1973 5
1974 8
1975 7
1976 16
1977 6
1978 12
1979 9
1980 10
1981 16
1982 11
1983 5
1984 20
1985 19
1986 20
1987 26
1988 24
1989 14
1990 17
1991 23
1992 34
1993 43
1994 47
1995 42
1996 57
1997 59
1998 76
1999 97
2000 85
2001 86
2002 100
2003 128
2004 128
2005 163
2006 208
2007 271
2008 307
2009 354
2010 388
2011 489
2012 590
2013 744
2014 895
2015 1001
2016 1008
2017 1010
2018 1192
2019 1379
2020 1706
2021 1997
2022 2347
2023 2282
2024 1237

Text availability

Article attribute

Article type

Publication date

Search Results

18,596 results

Results by year

Filters applied: . Clear all
Page 1
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
Hu Y, Zhang M, Yang T, Mo Z, Wei G, Jing R, Zhao H, Chen R, Zu C, Gu T, Xiao P, Hong R, Feng J, Fu S, Kong D, Xu H, Cui J, Huang S, Liang B, Yuan X, Cui Q, Guo H, Yu Y, Feng Y, Jin C, Ren J, Chang AH, Wang D, Huang H. Hu Y, et al. Among authors: yang t. N Engl J Med. 2024 Apr 25;390(16):1467-1480. doi: 10.1056/NEJMoa2313812. N Engl J Med. 2024. PMID: 38657244
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: yang ts. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Harnessing artificial intelligence for prostate cancer management.
Zhu L, Pan J, Mou W, Deng L, Zhu Y, Wang Y, Pareek G, Hyams E, Carneiro BA, Hadfield MJ, El-Deiry WS, Yang T, Tan T, Tong T, Ta N, Zhu Y, Gao Y, Lai Y, Cheng L, Chen R, Xue W. Zhu L, et al. Among authors: yang t. Cell Rep Med. 2024 Apr 16;5(4):101506. doi: 10.1016/j.xcrm.2024.101506. Epub 2024 Apr 8. Cell Rep Med. 2024. PMID: 38593808 Free PMC article. Review.
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
Takahashi M, Chong HB, Zhang S, Yang TY, Lazarov MJ, Harry S, Maynard M, Hilbert B, White RD, Murrey HE, Tsou CC, Vordermark K, Assaad J, Gohar M, Dürr BR, Richter M, Patel H, Kryukov G, Brooijmans N, Alghali ASO, Rubio K, Villanueva A, Zhang J, Ge M, Makram F, Griesshaber H, Harrison D, Koglin AS, Ojeda S, Karakyriakou B, Healy A, Popoola G, Rachmin I, Khandelwal N, Neil JR, Tien PC, Chen N, Hosp T, van den Ouweland S, Hara T, Bussema L, Dong R, Shi L, Rasmussen MQ, Domingues AC, Lawless A, Fang J, Yoda S, Nguyen LP, Reeves SM, Wakefield FN, Acker A, Clark SE, Dubash T, Kastanos J, Oh E, Fisher DE, Maheswaran S, Haber DA, Boland GM, Sade-Feldman M, Jenkins RW, Hata AN, Bardeesy NM, Suvà ML, Martin BR, Liau BB, Ott CJ, Rivera MN, Lawrence MS, Bar-Peled L. Takahashi M, et al. Among authors: yang ty. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22. Cell. 2024. PMID: 38653237
A spatiotemporal atlas of mouse liver homeostasis and regeneration.
Xu J, Guo P, Hao S, Shangguan S, Shi Q, Volpe G, Huang K, Zuo J, An J, Yuan Y, Cheng M, Deng Q, Zhang X, Lai G, Nan H, Wu B, Shentu X, Wu L, Wei X, Jiang Y, Huang X, Pan F, Song Y, Li R, Wang Z, Liu C, Liu S, Li Y, Yang T, Xu Z, Du W, Li L, Ahmed T, You K, Dai Z, Li L, Qin B, Li Y, Lai L, Qin D, Chen J, Fan R, Li Y, Hou J, Ott M, Sharma AD, Cantz T, Schambach A, Kristiansen K, Hutchins AP, Göttgens B, Maxwell PH, Hui L, Xu X, Liu L, Chen A, Lai Y, Esteban MA. Xu J, et al. Among authors: yang t. Nat Genet. 2024 May;56(5):953-969. doi: 10.1038/s41588-024-01709-7. Epub 2024 Apr 16. Nat Genet. 2024. PMID: 38627598
A spatiotemporal atlas of cholestatic injury and repair in mice.
Wu B, Shentu X, Nan H, Guo P, Hao S, Xu J, Shangguan S, Cui L, Cen J, Deng Q, Wu Y, Liu C, Song Y, Lin X, Wang Z, Yuan Y, Ma W, Li R, Li Y, Qian Q, Du W, Lai T, Yang T, Liu C, Ma X, Chen A, Xu X, Lai Y, Liu L, Esteban MA, Hui L. Wu B, et al. Among authors: yang t. Nat Genet. 2024 May;56(5):938-952. doi: 10.1038/s41588-024-01687-w. Epub 2024 Apr 16. Nat Genet. 2024. PMID: 38627596
Methanetriol─Formation of an Impossible Molecule.
Marks JH, Bai X, Nikolayev AA, Gong Q, Zhu C, Kleimeier NF, Turner AM, Singh SK, Wang J, Yang J, Pan Y, Yang T, Mebel AM, Kaiser RI. Marks JH, et al. Among authors: yang t. J Am Chem Soc. 2024 May 1;146(17):12174-12184. doi: 10.1021/jacs.4c02637. Epub 2024 Apr 17. J Am Chem Soc. 2024. PMID: 38629886
18,596 results
You have reached the last available page of results. Please see the User Guide for more information.